APA (7th ed.) Citation

Barth, P., Bruijnzeel, P., Wach, A., Sellier Kessler, O., Hooftman, L., Zimmermann, J., . . . Chevalier, E. (2020). Single dose escalation studies with inhaled POL6014, a potent novel selective reversible inhibitor of human neutrophil elastase, in healthy volunteers and subjects with cystic fibrosis. Journal of cystic fibrosis, 19(2), 299-304. https://doi.org/10.1016/j.jcf.2019.08.020

Chicago Style (17th ed.) Citation

Barth, P., et al. "Single Dose Escalation Studies with Inhaled POL6014, a Potent Novel Selective Reversible Inhibitor of Human Neutrophil Elastase, in Healthy Volunteers and Subjects with Cystic Fibrosis." Journal of Cystic Fibrosis 19, no. 2 (2020): 299-304. https://doi.org/10.1016/j.jcf.2019.08.020.

MLA (9th ed.) Citation

Barth, P., et al. "Single Dose Escalation Studies with Inhaled POL6014, a Potent Novel Selective Reversible Inhibitor of Human Neutrophil Elastase, in Healthy Volunteers and Subjects with Cystic Fibrosis." Journal of Cystic Fibrosis, vol. 19, no. 2, 2020, pp. 299-304, https://doi.org/10.1016/j.jcf.2019.08.020.